Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Jeannette L BennicelliJean Bennett

Abstract

We evaluated the safety and efficacy of an optimized adeno-associated virus (AAV; AAV2.RPE65) in animal models of the RPE65 form of Leber congenital amaurosis (LCA). Protein expression was optimized by addition of a modified Kozak sequence at the translational start site of hRPE65. Modifications in AAV production and delivery included use of a long stuffer sequence to prevent reverse packaging from the AAV inverted-terminal repeats, and co-injection with a surfactant. The latter allows consistent and predictable delivery of a given dose of vector. We observed improved electroretinograms (ERGs) and visual acuity in Rpe65 mutant mice. This has not been reported previously using AAV2 vectors. Subretinal delivery of 8.25 x 10(10) vector genomes in affected dogs was well tolerated both locally and systemically, and treated animals showed improved visual behavior and pupillary responses, and reduced nystagmus within 2 weeks of injection. ERG responses confirmed the reversal of visual deficit. Immunohistochemistry confirmed transduction of retinal pigment epithelium cells and there was minimal toxicity to the retina as judged by histopathologic analysis. The data demonstrate that AAV2.RPE65 delivers the RPE65 transgene efficiently and...Continue Reading

Associated Clinical Trials

References

Sep 1, 1989·The British Journal of Ophthalmology·K NarfströmS E Nilsson
Apr 28, 2001·Nature Genetics·G M AclandJ Bennett
May 17, 2002·Human Molecular Genetics·Frans P M CremersAnneke I den Hollander
Mar 27, 2003·Investigative Ophthalmology & Visual Science·Kristina NarfströmP Elizabeth Rakoczy
Apr 15, 2003·The Journal of Heredity·K NarfströmR Bragadóttir
Aug 2, 2003·Progress in Retinal and Eye Research·Debra A Thompson, Andreas Gal
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nadine S DejnekaJean Bennett
Oct 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory M AclandSamuel G Jacobson
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Y UminoR B Barlow
Jun 5, 2007·Nature Genetics·Anneke I den HollanderRonald Roepman

❮ Previous
Next ❯

Citations

Dec 24, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Keiko MiyaderaDavid R Sargan
May 31, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Robert B HufnagelRobert A Sisk
Aug 13, 2010·Gene Therapy·M J AnnearS M Petersen-Jones
Sep 4, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Helen FosterGeorge Dickson
Dec 3, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Francesca SimonelliAlberto Auricchio
Jan 13, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Hyung JangDavid V Schaffer
Apr 1, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elsa LhériteauFabienne Rolling
Apr 29, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Virginia HaurigotKatherine A High
Jan 30, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shannon E BoyeWilliam W Hauswirth
Mar 16, 2013·Nature Reviews. Drug Discovery·Guillaume VaquerBruno Sepodes
Apr 29, 2008·The New England Journal of Medicine·Joan W Miller
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
Aug 17, 2012·The New England Journal of Medicine·Elaine A Ostrander
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Artur V CideciyanWilliam W Hauswirth
May 2, 2012·Human Gene Therapy·Arpad PalfiG Jane Farrar
Jul 18, 2008·Briefings in Functional Genomics & Proteomics·Alejandro Negrete, Robert M Kotin
Oct 25, 2011·Journal of Paediatrics and Child Health·Samantha L Ginn, Ian E Alexander
Feb 11, 2012·Science Translational Medicine·Jean BennettAlbert M Maguire
Sep 3, 2010·The Journal of Clinical Investigation·Anneke I den HollanderFrans P M Cremers
May 25, 2011·The Journal of Clinical Investigation·Manzar AshtariJean Bennett
Aug 6, 2011·PloS One·Marianthi KaraliAlberto Auricchio
Sep 26, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Amir RattnerJeremy Nathans
Jan 8, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Priyanka PatelJean-Pierre Julien
Feb 8, 2014·Human Gene Therapy·Rachel M Huckfeldt, Jean Bennett
Nov 5, 2010·Journal of Ophthalmology·Maria A Musarella, Ian M Macdonald
Jun 13, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tanya TolmachovaMiguel C Seabra
Jun 21, 2014·Visual Neuroscience·G Jane FarrarArpad Palfi
Mar 22, 2014·Human Molecular Genetics·Budd A TuckerEdwin M Stone
Sep 22, 2012·Progress in Retinal and Eye Research·Daniel M LipinskiRobert E MacLaren
Aug 21, 2010·Experimental Eye Research·Thomas J GioveWilliam D Eldred
Apr 20, 2010·Progress in Retinal and Eye Research·Artur V Cideciyan
Jan 12, 2010·The Veterinary Journal·András M Komáromy
Dec 17, 2009·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Daniel C Chung, Elias I Traboulsi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.